Does Rallies show Form 4 insider transactions for MGRX?

Yes. Rallies tracks MGRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MGRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.

MGRX (Mangoceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

Mangoceuticals, Inc. Common Stock (MGRX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGRX trades at $0.42 with a market cap of $6.87M and a P/E ratio of -0.19. MGRX moved +1.62% today. Year to date, MGRX is -48.49%; over the trailing twelve months it is -72.97%. Its 52-week range spans $0.16 to $7.66. Rallies surfaces MGRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MGRX stock inside the company?

Recent MGRX insider activity includes JOHNSTON EUGENE M sold 3.33K, JOHNSTON EUGENE M sold 5.00K, JOHNSTON EUGENE M sold 10.00K, Hamilton Alex P. sold 125.00K, and Hamilton Alex P. sold 108.43K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MGRX Key Metrics

Key financial metrics for MGRX
Metric	Value
Price	$0.42
Market Cap	$6.87M
P/E Ratio	-0.19
EPS	$-2.17
Dividend Yield	0.00%
52-Week High	$7.66
52-Week Low	$0.16
Volume	3.21K
Avg Volume	0
Revenue (TTM)	$456.02K
Net Income	$-20.64M
Gross Margin	54.91%

Recent MGRX Insider Trades

JOHNSTON EUGENE M sold 3.33K (~$3.88K) on Dec 15, 2025.
JOHNSTON EUGENE M sold 5.00K (~$5.97K) on Dec 9, 2025.
JOHNSTON EUGENE M sold 10.00K (~$11.28K) on Dec 5, 2025.
Hamilton Alex P. sold 125.00K (~$152.88K) on Nov 19, 2025.
Hamilton Alex P. sold 108.43K (~$34.70K) on Jun 26, 2024.

Latest MGRX News

Mangoceuticals Seeks Global Patent for MGX-0024 in Over 150 Countries after 29,000-Bird Trial — Mar 6, 2026
Mangoceuticals Sees Zero Respiratory Mortality in 29,000-Bird Trial and 60% H5N1 Death Reduction — Feb 23, 2026
Mangoceuticals Shares Soar 50% After 336% Sales Surge for $99 TRT Program — Feb 20, 2026
MangoRx’s $99 TRT Program Drives 336% Sales Surge, Cuts CAC by 54% — Feb 19, 2026

MGRX Analyst Consensus

MGRX analyst coverage data. Average price target: $0.00.

Common questions about MGRX

Who is trading MGRX stock inside the company?: Recent MGRX insider activity includes JOHNSTON EUGENE M sold 3.33K, JOHNSTON EUGENE M sold 5.00K, JOHNSTON EUGENE M sold 10.00K, Hamilton Alex P. sold 125.00K, and Hamilton Alex P. sold 108.43K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MGRX?: Yes. Rallies tracks MGRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MGRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MGRX. It does not provide personalized investment advice.